Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · IEX Real-Time Price · USD
13.16
+0.01 (0.08%)
At close: Apr 18, 2024, 4:00 PM
13.18
+0.02 (0.11%)
Pre-market: Apr 19, 2024, 8:40 AM EDT
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $41.29 billion as of April 19, 2024. Its market cap has decreased by -19.87% in one year.
Market Cap
41.29B
Enterprise Value
74.58B
1-Year Change
-19.87%
Ranking
Category
Stock Price
$13.16
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $41.29B, a decrease of -42.01%. That is a compound annual growth rate of -3.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 41.29B | 0.08% |
Apr 17, 2024 | 41.26B | -0.60% |
Apr 16, 2024 | 41.51B | 0.38% |
Apr 15, 2024 | 41.36B | -1.42% |
Apr 12, 2024 | 41.95B | -1.55% |
Apr 11, 2024 | 42.61B | 0.07% |
Apr 10, 2024 | 42.58B | -0.59% |
Apr 9, 2024 | 42.83B | -0.15% |
Apr 8, 2024 | 42.89B | 0.37% |
Apr 5, 2024 | 42.74B | 1.04% |
Apr 4, 2024 | 42.30B | -0.37% |
Apr 3, 2024 | 42.45B | -0.15% |
Apr 2, 2024 | 42.52B | -0.88% |
Apr 1, 2024 | 42.89B | -1.58% |
Mar 28, 2024 | 43.58B | -2.11% |
Mar 27, 2024 | 44.53B | -1.39% |
Mar 26, 2024 | 45.15B | 1.70% |
Mar 25, 2024 | 44.40B | -1.80% |
Mar 22, 2024 | 45.22B | 0.35% |
Mar 21, 2024 | 45.06B | -1.31% |
Mar 20, 2024 | 45.66B | 0.97% |
Mar 19, 2024 | 45.22B | -1.03% |
Mar 18, 2024 | 45.69B | 0.62% |
Mar 15, 2024 | 45.40B | 0.91% |
Mar 14, 2024 | 45.00B | -0.55% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Becton, Dickinson and Company | 67.25B |
Edwards Lifesciences | 53.59B |
DexCom | 52.25B |
Cencora | 47.39B |
IQVIA Holdings | 41.91B |
IDEXX Laboratories | 40.98B |
Moderna | 40.41B |
Agilent Technologies | 40.14B |